Active Pharmaceutical Ingredients (API)

Key Highlights Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and obesity treatment, sold under Ozempic®, Wegovy®, and Rybelsus®.…

Synopsis:- Joenja is the first drug approved in the U.S.  for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in…

Synopsis First and only approved therapy for Rett syndrome, a rare, neurodevelopmental disorder, which affects 6,000 to 9,000 patients in the U.S.…

On May 12, the U.S. Food and Drug Administration (FDA) approved VEOZAHTM (Fezolinetant), 45 mg once daily for the treatment of moderate…

Summary:- INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or…

Summary : IMCIVREE now available for chronic weight management in adult and pediatric patients 6 years of age and older with monogenic…

Summary : Pfizer Chief Executive Officer Albert Bourla called 2021 a watershed year for the company. It posted $81.3 billion in revenue…

Summary : EMA’s human medicines committe  has recommended granting  conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 / ritonavir) for…

SYNOPSIS: Takeda announced that U.S. FDA Approved LIVTENCITY (Maribavir) as the First and Only Treatment for People Ages 12 or older and…

Abstract: The European Commission has approved Pfizer`s first-of-its-kind oral Janus kinase (JAK) inhibitor  XELJANZ® (Tofacitinib) 5 mg twice daily for the treatment…